Wendy Yarno
Directeur/Membre du Conseil chez TARSUS PHARMACEUTICALS, INC.
Fortune : 348 741 $ au 30/06/2024
Profil
Wendy L.
Yarno is currently serving as an Independent Director at Inovio Pharmaceuticals, Inc., Iovance Biotherapeutics, Inc., IDEAYA Biosciences, Inc., and as the Lead Independent Director at Tarsus Pharmaceuticals, Inc. Previously, she held positions as the Non-Executive Chairman at Aratana Therapeutics, Inc., Independent Director at St. Jude Medical LLC, Director at PluroGen Therapeutics, Inc. and Adial Pharmaceuticals, Inc., Independent Director at MyoKardia, Inc. and Medivation LLC (California), Director at Durata Therapeutics, Inc., and Independent Director at Global Blood Therapeutics, Inc. She also served as Vice President-Women's Health Care Franchise at Johnson & Johnson and Chief Marketing Officer & Executive Vice President at Merck & Co., Inc. Additionally, she was the Chief Marketing Officer at HemoShear Therapeutics, Inc. and held a Vice President-Women's Healthcare Franchise position at Ortho-McNeil Pharmaceutical LLC.
Ms. Yarno obtained her undergraduate degree from Portland State University in 1982 and an MBA from Fox School of Business in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2024 | 10 350 ( 0,03% ) | 281 313 $ | 30/06/2024 | |
| 21/05/2024 | 8 345 ( 0,03% ) | 67 428 $ | 30/06/2024 | |
IDEAYA BIOSCIENCES, INC.
-.--% | 31/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Wendy Yarno
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 06/12/2017 |
| IDEAYA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 17/12/2019 |
| TARSUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/11/2020 |
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/04/2023 |
Anciens postes connus de Wendy Yarno
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/10/2022 |
| MYOKARDIA, INC. | Directeur/Membre du Conseil | 17/11/2020 |
| ARATANA THERAPEUTICS INC | Président | 18/07/2019 |
| ST JUDE MEDICAL INC | Directeur/Membre du Conseil | 01/01/2017 |
| MEDIVATION INC | Directeur/Membre du Conseil | 28/09/2016 |
Formation de Wendy Yarno
| Portland State University | Undergraduate Degree |
| Fox School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| ADIAL PHARMACEUTICALS, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
PluroGen Therapeutics, Inc.
 PluroGen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PluroGen Therapeutics LLC provides clinically advanced and advantaged burn, wound and skin care products. The firm also provides online ordering services. PluroGen Therapeutics was founded by George T. Rodeheaver and Adam J. Katz in February 2003 and is headquartered in Norristown, PA. | Health Technology |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
